We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Combining Guidances Related To Diabetes Drug Development
FDA Combining Guidances Related To Diabetes Drug Development
October 8, 2010
The FDA will merge two guidances — a draft guidance on developing diabetes drugs and a final guidance on evaluating risk in those drugs — and issue a combined document for industry.